Product Images Lithium Carbonate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Lithium Carbonate NDC 51079-180 by Mylan Institutional Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Lithium Carbonate Extended-Release 300 mg Tablets Unit Carton Label - image 01
This is a description of Lithium Carbonate Extended-Release Tablets. The NDC code is 51079-180-20, and each tablet contains 300 mg of Lithium Carbonate USP. The usual dosage and warnings are provided with the product. The tablets should be stored between 20° to 25°C and protected from moisture. They are manufactured by Mylan Pharmaceuticals in Morgantown, WV.*
Serialized Unit Carton - image 02
This is a package warning for Mylan® drugs. The package is not child-resistant, so it should be kept away from children. The container provides light-resistance. It is intended for institutional use only. The package has information about the lot number and expiration date. The drug is manufactured by Mylan® in Rockford, USA.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.